Financial Performance And Margin StrengthHaleon is expected to have above-sector margins and strong cash conversion leading to a healthy EPS CAGR of around 7.6%.
Market Leadership And Growth OpportunitiesHaleon's global leadership in core categories and therapeutic oral care provides opportunities for category penetration and growth in emerging markets.
Strategic Initiatives And FlexibilityHaleon's disposals are accretive for growth and provide flexibility for debt reduction, M&A opportunities, and share buybacks.